All Stories

  1. CNTF specifically slows down the axonal transport of signalling endosomes
  2. TBK1 activity regulates the directionality of axonal transport of signalling endosomes
  3. Processivity and BDNF-dependent modulation of signalling endosome axonal transport are impaired in mice with advanced age
  4. Processivity and BDNF-dependent modulation of signalling endosome axonal transport are impaired in aged mice
  5. Shared mechanisms and pathological phenotypes underlying aminoacyl-tRNA synthetase-related neuropathies
  6. Refining gene delivery to skeletal muscle with a dual-strategy approach of muscle-tropic AAV capsids and muscle-specific promoters
  7. The tyrosine phosphatases LAR and PTPRδ act as receptors of the nidogen-tetanus toxin complex
  8. Age‐specific and compartment‐dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons
  9. The node of Ranvier influences thein vivoaxonal transport of mitochondria and signalling endosomes
  10. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy
  11. Targeting muscle to treat Charcot-Marie-Tooth disease
  12. Brain-derived neurotrophic factor amplifies neuron-intrinsic programs to enhance axonal regeneration in human motor neurons
  13. Age-specific and compartment-dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons
  14. Spinal Muscular Atrophy: A Rare but Treatable Disease of the Nervous System
  15. Boosting peripheral BDNF rescues impaired in vivo axonal transport in CMT2D mice
  16. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy
  17. In vivo imaging of axonal transport in peripheral nerves of rodent forelimbs
  18. Neuroscience highlights in 2022: cytoskeletal transport
  19. Intraperitoneal Injection of Neonatal Mice
  20. Hydrogen peroxide induced by nerve injury promotes axon regeneration via connective tissue growth factor
  21. Editorial: Peripheral nerve anatomy in health and disease
  22. BDNF-dependent modulation of axonal transport is selectively impaired in ALS
  23. Editorial: Pathways and Processes Underpinning Axonal Biology and Pathobiology
  24. Coupling axonal mRNA transport and local translation to organelle maintenance and function
  25. Expanding the Toolkit for <em>In Vivo</em> Imaging of Axonal Transport
  26. A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease
  27. BDNF-dependent modulation of axonal transport is selectively impaired in ALS
  28. Dissection, in vivo imaging and analysis of the mouse epitrochleoanconeus muscle
  29. NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
  30. NMJ-Analyser: high-throughput morphological screening of neuromuscular junctions identifies subtle changes in mouse neuromuscular disease models
  31. Altered Sensory Neuron Development in CMT2D Mice Is Site-Specific and Linked to Increased GlyRS Levels
  32. Intramuscular Delivery of Gene Therapy for Targeting the Nervous System
  33. Developmental demands contribute to early neuromuscular degeneration in CMT2D mice
  34. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  35. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  36. Morphological variability is greater at developing than mature mouse neuromuscular junctions
  37. Developmental demands contribute to early neuromuscular degeneration in CMT2D mice
  38. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  39. Altered sensory neuron development in CMT2D mice is site-specific and linked to increased GlyRS levels
  40. Post-synaptic morphology of mouse neuromuscular junctions is linked to muscle fibre type
  41. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy
  42. Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes
  43. Axonal Transport: The Delivery System Keeping Nerve Cells Alive
  44. In Vivo Imaging of Anterograde and Retrograde Axonal Transport in Rodent Peripheral Nerves
  45. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy
  46. The evolution of the axonal transport toolkit
  47. Axonal transport and neurological disease
  48. Neuronal over-expression of OXR1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo
  49. Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition
  50. ALS mice carrying pathological mutant TDP-43, but not mutant FUS, display axonal transport defects in vivo
  51. UBA1/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy
  52. Plexin-Semaphorin Signaling Modifies Neuromuscular Defects in a Drosophila Model of Peripheral Neuropathy
  53. Antisense oligonucleotides and other genetic therapies made simple
  54. Aligned electrospun fibers for neural patterning
  55. Engineered method for directional growth of muscle sheets on electrospun fibers
  56. Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
  57. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis
  58. Sensory neuron fate is altered in human neuropathy caused by Gars mutations
  59. Methodological advances in imaging intravital axonal transport
  60. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular development and homeostasis
  61. Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
  62. Sensory neuron fate is developmentally perturbed by Gars mutations causing human neuropathy
  63. Axonal transport is unnaffected by aging
  64. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d
  65. A simple, step-by-step dissection protocol for the rapid isolation of mouse dorsal root ganglia
  66. Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy
  67. In vivo imaging of axonal transport in murine motor and sensory neurons
  68. The muscle is a major player in neuropathology of a fly model of peripheral neuropathy
  69. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles
  70. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
  71. Delayed motor neuron-muscle synapse development anticipates degeneration in peripheral neuropathy
  72. Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
  73. Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease
  74. Spinal muscular atrophy at the crossroads of basic science and therapy
  75. Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
  76. The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
  77. Conserved Genes Act as Modifiers of Invertebrate SMN Loss of Function Defects
  78. A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds
  79. Functional analysis of nematode nicotinic receptors
  80. C. elegans models of neuromuscular diseases expedite translational research